Biguanide Market to Hit USD 18.7 Billion by 2031 Due to Rising...

Biguanide Market to Hit USD 18.7 Billion by 2031 Due to Rising Diabetes Rates and Broader Therapeutic Uses

2025-07-29 08:25:01 • مشاهدة

[London, 29 July 2025] – The global biguanide market is projected to grow from USD 10.4 billion in 2024 to USD 18.7 billion by 2031, reflecting a compound annual growth rate (CAGR) of 8.4%, according to Clearview Market Insights (CVMI). Metformin continues to lead as the most prescribed oral treatment for type 2 diabetes and is increasingly being used in PCOS, oncology, and geriatric care.

“Metformin is no longer just a diabetes drug — it’s a platform molecule for multiple chronic and preventative applications,” said Dr. Salim Patel, Therapeutics Lead at CVMI.

Request Sample: https://clearviewmarketinsights.com/report-details/global-biguanide-market/

Asia-Pacific remains the largest and fastest-growing regional market due to high diabetes incidence and extensive procurement by public health systems. North America and Europe demonstrate strong demand for extended-release and combination formulations. Companies like Teva, Sun Pharma, and Merck KGaA are leading innovations in packaging, delivery, and new indications.

Ongoing innovations include metformin implants, AI-driven dosing platforms, and new analogs targeting metabolic and mitochondrial pathways. Meanwhile, WHO-backed procurement and regulatory flexibility are enhancing access in lower-income countries.

For more insights, visit https://clearviewmarketinsights.com/

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!

انضم إلينا

اللغات

Biguanide Market to Hit USD 18.7 Billion by 2031 Due to Rising Diabetes Rates and Broader Therapeutic Uses

GCC Electric Vehicle Market to Grow at 35.5% CAGR: Key Trends & Insights